awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38165773-0BAC1F53-C5FA-491F-8687-249D35926208
Q38165773-0BAC1F53-C5FA-491F-8687-249D35926208
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38165773-0BAC1F53-C5FA-491F-8687-249D35926208
Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer.
P2860
Q38165773-0BAC1F53-C5FA-491F-8687-249D35926208
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38165773-0BAC1F53-C5FA-491F-8687-249D35926208
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e74d3e6c39af72dacbcd16835bea7992d6dd618
P2860
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.